Fact, mental health startup, investigated by the DEA
The United States Drug Enforcement Agency is investigating mental health startup Done for its prescription of controlled substances, according to a report.
The Wall Street Journal first report on the investigation.
According to the report, the DEA’s Diversion Control Division is investigating Done and another online mental health startup, Cerebral, over their prescription of Adderall and other controlled substances.
A spokesperson for Done said the company had “not received any notification from the DEA, the Department of Justice, or any other federal agency regarding an investigation, filing, or record retention.”
Done’s spokesperson said the company does not treat or determine diagnoses for people with ADHD, but provides a “platform that allows individuals to connect with qualified clinicians to diagnose and treat patients with ADHD. ADHD”. The company said these clinicians are neither employees nor contractors.
A spokesperson for Cerebral said it was not commenting on ongoing investigations, but added that the company was cooperating fully with any investigation. A DEA spokesperson had no comment.
Download Modern Healthcare’s app to stay informed when industry news breaks.
Cerebral has reportedly been linked to several federal government investigations. In June, the US Federal Trade Commission reportedly sent a letter to Cerebral requesting information on whether the company continued to bill patients even after trying to cancel their subscriptions. According to the report, the FTC asked Cerebral to keep the relevant documents.
Cerebral received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York in May regarding an investigation into “possible violations of the Controlled Substances Act” related to the way he prescribed drugs. ADHD medications. It is unclear whether this investigation is related to one allegedly conducted by the DEA.
In response to the grand jury subpoena in May, Cerebral said she had not been charged with breaking any laws. The company announced the same day that it would no longer prescribe certain controlled substances to treat ADHD. In late May, Walmart, CVS Health and other national drugstore chains announced they would stop filling ADHD medications from Cerebral and Done.
This story first appeared in Digital Health Business & Technology.